These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9661691)

  • 1. Hepatitis A virus infections associated with clotting factor concentrate in the United States.
    Soucie JM; Robertson BH; Bell BP; McCaustland KA; Evatt BL
    Transfusion; 1998 Jun; 38(6):573-9. PubMed ID: 9661691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An outbreak of hepatitis A among South African patients with hemophilia: evidence implicating contaminated factor VIII concentrate as the source.
    Kedda MA; Kew MC; Cohn RJ; Field SP; Schwyzer R; Song E; Fernandes-Costa F
    Hepatology; 1995 Nov; 22(5):1363-7. PubMed ID: 7590648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transmission of hepatitis A to patients with hemophilia by factor VIII concentrates treated with organic solvent and detergent to inactivate viruses. The Italian Collaborative Group.
    Mannucci PM; Gdovin S; Gringeri A; Colombo M; Mele A; Schinaia N; Ciavarella N; Emerson SU; Purcell RH
    Ann Intern Med; 1994 Jan; 120(1):1-7. PubMed ID: 7504424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis A virus sequence detected in clotting factor concentrates associated with disease transmission.
    Robertson BH; Alter MJ; Bell BP; Evatt B; McCaustland KA; Shapiro CN; Sinha SD; Souci JM
    Biologicals; 1998 Jun; 26(2):95-9. PubMed ID: 9811512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virology of the hepatitis A epidemic in Italy.
    Purcell RH; Mannucci PM; Gdovin S; Gringeri A; Colombo M; Mele A; Schinaia N; Ciavarella N; Emerson SU
    Vox Sang; 1994; 67 Suppl 4():2-7; discussion 24-6. PubMed ID: 7831866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis A among persons with hemophilia who received clotting factor concentrate--United States, September-December 1995.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Jan; 45(2):29-32. PubMed ID: 8531917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Has hepatitis A virus been transmitted by clotting factor concentrates among hemophiliacs in the United States?
    Mosley JW
    Vox Sang; 1994; 67 Suppl 4():12-5; discussion 24-6. PubMed ID: 7831863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new cluster of hepatitis A infection in hemophiliacs traced to a contaminated plasma pool.
    Chudy M; Budek I; Keller-Stanislawski B; McCaustland KA; Neidhold S; Robertson BH; Nübling CM; Seitz R; Löwer J
    J Med Virol; 1999 Feb; 57(2):91-9. PubMed ID: 9892390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequence variability of hepatitis A virus and factor VIII associated hepatitis A infections in hemophilia patients in Europe. An update.
    Robertson BH; Friedberg D; Normann A; Graff J; Flehmig B; Shouval D
    Vox Sang; 1994; 67 Suppl 1():39-45; discussion 46. PubMed ID: 8091736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From the Centers for Disease Control and Prevention. Hepatitis A among persons with hemophilia who received clotting factor concentrate--United States, September-December 1995.
    JAMA; 1996 Feb; 275(6):427-8. PubMed ID: 8627951
    [No Abstract]   [Full Text] [Related]  

  • 11. The outbreak of hepatitis A in Italian patients with hemophilia: facts and fancies.
    Mannucci PM; Santagostino E; Di Bona E; Gentili G; Ghirardini A; Schiavoni M; Mele A
    Vox Sang; 1994; 67 Suppl 1():31-5. PubMed ID: 8091734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis A virus infection among the hemophilia population at the Bonn Hemophilia Center.
    Brackmann HH; Oldenburg J; Eis-Hübinger AM; Gerritzen A; Hammerstein U; Hanfland P
    Vox Sang; 1994; 67 Suppl 1():3-7; discussion 8. PubMed ID: 8091733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human T-lymphotropic retrovirus type III/lymphadenopathy-associated virus antibody. Association with hemophiliacs' immune status and blood component usage.
    Jason J; McDougal JS; Holman RC; Stein SF; Lawrence DN; Nicholson JK; Dixon G; Doxey M; Evatt BL
    JAMA; 1985 Jun; 253(23):3409-15. PubMed ID: 2987559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis A in French hemophiliacs.
    Goudemand J; Parquet A; d'Oiron R; Stieltjes N; Guérois C; Fonlupt J; Alcalay M; Négrier C; Cazenave JP; Briquel ME
    Vox Sang; 1994; 67 Suppl 1():9-12; discussion 13. PubMed ID: 8091745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of hepatitis A virus from clotting factors implicated as a source of HAV infection among haemophilia patients in Korea.
    Jee YM; Go U; Cheon D; Kang Y; Yoon JD; Lee SW; Shin YH; Kim KS; Lee JK; Jeong EK; Yang BK; Cho HW
    Epidemiol Infect; 2006 Feb; 134(1):87-93. PubMed ID: 16409654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An outbreak of hepatitis A among Irish haemophiliacs.
    Johnson Z; Thornton L; Tobin A; Lawlor E; Power J; Hillary I; Temperley I
    Int J Epidemiol; 1995 Aug; 24(4):821-8. PubMed ID: 8550281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure to detect hepatitis A virus RNA in factor VIII concentrates using the polymerase chain reaction. Results of a preliminary study.
    McOmish F; Yap PL; Hart H; Peerlinck K; Burns SM; Simmonds P
    Vox Sang; 1994; 67 Suppl 1():47-50. PubMed ID: 8091737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective study of the evaluation of hepatitis C virus infectivity in a high-purity, solvent/detergent-treated factor VIII concentrate: parallel evaluation of other markers for lipid-enveloped and non-lipid-enveloped viruses. The Ad Hoc Study Group of the Fondazione dell'Emofilia.
    Mariani G; Di Paolantonio T; Baklaya R; Morfini M; Mannucci PM
    Transfusion; 1993 Oct; 33(10):814-8. PubMed ID: 8236421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis A virus infection in tamarins: experimental transmission via contaminated factor VIII concentrates.
    Chudy M; Stahl-Hennig C; Berger A; Nübling CM; Hunsmann G; Rabenau HF; Löwer J
    J Infect Dis; 2002 Apr; 185(8):1170-3. PubMed ID: 11930328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis A virus and polymerase chain reaction amplification: methodology and results.
    Robertson BH; Normann A; Graff J; Flehmig B; Friedberg D; Shouval D
    Blood Coagul Fibrinolysis; 1995 Jul; 6 Suppl 2():S27-31. PubMed ID: 7495964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.